tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports
Want to see FDMT full AI Analyst Report?

4D Molecular Therapeutics (FDMT) Revenue

519 Followers
StatisticsMarket CapRevenue

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had a revenue of 3.05M in the quarter ending Mar 31, 2026, with -96.42%. This bring the company's revenue in the last twelve months to 88.24M, Decreased 3.56%. In the fiscal year ending Dec 31, 2025, 4D Molecular Therapeutics had annual revenue of 85.21M with 230194.59% growth.
Revenue (ttm)
88.24M
Revenue Growth
383560.87%
P/S Ratio
5.61
Revenue/Employee
$375,370
Employees
227
Market Cap
$478.31M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
85.21M85.17M+230,194.59%
Dec 31, 2024
37.00K-20.69M-99.82%
Dec 31, 2023
20.72M17.59M+562.29%
Dec 31, 2022
3.13M-14.91M-82.65%
Dec 31, 2021
18.04M4.43M+32.52%
Dec 31, 2020
13.61M6.63M+94.85%
Dec 31, 2019
6.99M-7.14M-50.56%
Dec 31, 2018
14.13M8.34M+144.04%
Dec 31, 2017
5.79M――